Dr. Steven Young Park, MD

Dr. Park practices at UHS Binghamton General Hospital in Binghamton, New York, part of United Health Services.

Dr. Park's NPI, 1962477042, was assigned on February 22, 2006. Dr. Park graduated from Vagelos College of Physicians and Surgeons in 1993. Dr. Park holds Pennsylvania license MD483193.

Dr. Park's primary practice is UHS Binghamton General Hospital, at 10-42 Mitchell Avenue, Binghamton, NY 13903 in Broome County. The practice phone is (607) 763-6000. Dr. Park also practices at United Health Services Hospitals, 1042 Mitchell Ave, Binghamton, NY 13903.

Dr. Park's primary practice is UHS Binghamton General Hospital in Binghamton, New York, part of United Health Services. Dr. Park is also affiliated with Guthrie Lourdes Hospital. The medical group on file is UHS Wilson Medical Center. Dmand AI also links Dr. Park to 1 more hospital, 7 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Park practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Park's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Park is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Park's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 296 Medicare services from Dr. Park across 7 procedure codes in 2024, for 163 Medicare patients. Medicare paid $24,714 for them. Every service was in an office.

CMS counts 163 Medicare patients who saw Dr. Park in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Park's median patient age at 64, with 48% women.

In 2024, Dr. Park wrote 38 Medicare Part D claims for 22 patients. 97% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $493 in total drug cost. In 2021, CMS named 70 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Park for performance year 2024, reported as part of a group. Dr. Park accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 45 papers to Dr. Park, published from 2011 to 2025. 2021 was the busiest year, with 7. The most frequent topics are COVID-19, SARS-CoV-2 and Microbial Sensitivity Tests. Dr. Park has published most often in Antimicrob Agents Chemother. Dr. Park's most frequent co-authors are Janice M. Cheong, MD, Michele L. Donato, MD and Steven Park, MD.

Dmand AI links Dr. Park to 2 clinical trials. Conditions studied include Gastroesophageal Reflux, Sleep Apnea, Obstructive and Esophageal Motility Disorders. West Side ENT sponsors the most, 2.

CMS Open Payments shows 4 general payments to Dr. Park from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $43.

Dmand AI lists 1 award for Dr. Park.

Dr. Park graduated from Vagelos College of Physicians and Surgeons in 1993. Dr. Park is a member of NHS.

Dr. Park is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.